A daily yogurt drink might strengthen your immune defenses

NCT ID NCT07799207

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

Researchers are testing whether drinking a yogurt every day for 8 weeks can improve immune function in healthy adults aged 18 to 65. Participants will be randomly assigned to receive either the yogurt drink or a placebo, and researchers will measure immune markers in saliva, as well as track cold symptoms, quality of life, and sleep. The goal is to see if a simple dietary addition can support the body's natural defenses.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A yogurt drink taken daily for 8 weeks
What this could lead to
If daily yogurt strengthens immune markers and reduces cold-like symptoms, it could support a simple dietary habit for better everyday health.
What could go wrong
This is a small, early-stage trial, and results may not apply to everyone. The placebo drink also contains lactic acid, so differences could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 118 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be able to give written informed consent. * Be between 18-65 years, inclusive. * Be in general good health, as determined by the in investigator. * Willing to consume study product daily for the duration of the study. * Has a body mass index (BMI) ≤39.9 kg/m2 * Willing to refrain from consuming alcohol for the 24 hours prior to each study visit. * Willing to maintain current lifestyle habits, including dietary and caffeine and alcohol intake, for the duration of the study. Exclusion Criteria: * Participants who are pregnant or wish to become pregnant during the study or who are lactating and/or currently breastfeeding. * Participants currently of biological childbearing potential, but not using a continuous effective method of contraception. * Has a history of drug and/or alcohol abuse at the time of enrolment. * Drinks more than nationally recommended units of alcohol per day/week. * Has milk allergy or other food allergies or other issues with foods that would preclude intake of the SP. * Has an excessive smoking habit. * Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requirements, put the participant at risk or would confound the interpretation of the study results as judged by the investigator on the basis of medical history and laboratory test results. * Dental or intraoral treatment. * Visited a hospital or clinic for allergic rhinitis (pollinosis) within the past year or those who plan to take prescription drugs to treat or prevent allergic rhinitis during the study period. * Current or recent (in the past 4 weeks) use of a medication that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. * Current or recent (in the past 4-weeks) use of prohibited nutritional or non-nutritional dietary supplements that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. * Current or recent (in the past 2 weeks) use of yogurt (other than the study product) * Participants who have donated blood in the previous 8-weeks. * Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the study. * Participants may not be participating in other clinical studies. If the participant has previously taken part in an experimental study, the Investigator must ensure sufficient time has elapsed before entry to this study to ensure the integrity of the results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Immune function are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Atlantia Clinical Trials

    RECRUITING

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.